Logo image of AIRI

AIR INDUSTRIES GROUP (AIRI) Stock Fundamental Analysis

NYSEARCA:AIRI - NYSE Arca - US00912N4034 - Common Stock - Currency: USD

3.9  -0.05 (-1.27%)

After market: 3.8522 -0.05 (-1.23%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AIRI. AIRI was compared to 66 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of AIRI have multiple concerns. While showing a medium growth rate, AIRI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AIRI has reported negative net income.
In the past year AIRI has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AIRI reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: AIRI reported negative operating cash flow in multiple years.
AIRI Yearly Net Income VS EBIT VS OCF VS FCFAIRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

AIRI has a Return On Assets of -1.25%. This is in the lower half of the industry: AIRI underperforms 65.63% of its industry peers.
AIRI's Return On Equity of -4.30% is on the low side compared to the rest of the industry. AIRI is outperformed by 62.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.85%, AIRI is in line with its industry, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
ROA -1.25%
ROE -4.3%
ROIC 3.85%
ROA(3y)-1.05%
ROA(5y)-1.32%
ROE(3y)-3.69%
ROE(5y)-6.11%
ROIC(3y)N/A
ROIC(5y)N/A
AIRI Yearly ROA, ROE, ROICAIRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Operating Margin, with a value of 2.14%, AIRI is doing worse than 64.06% of the companies in the same industry.
The Gross Margin of AIRI (16.10%) is worse than 73.44% of its industry peers.
AIRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.14%
PM (TTM) N/A
GM 16.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.53%
GM growth 5Y3.33%
AIRI Yearly Profit, Operating, Gross MarginsAIRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AIRI is destroying value.
AIRI has more shares outstanding than it did 1 year ago.
AIRI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AIRI has been reduced compared to a year ago.
AIRI Yearly Shares OutstandingAIRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
AIRI Yearly Total Debt VS Total AssetsAIRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

AIRI has an Altman-Z score of -0.26. This is a bad value and indicates that AIRI is not financially healthy and even has some risk of bankruptcy.
AIRI has a Altman-Z score of -0.26. This is amonst the worse of the industry: AIRI underperforms 85.94% of its industry peers.
A Debt/Equity ratio of 0.54 indicates that AIRI is somewhat dependend on debt financing.
AIRI has a Debt to Equity ratio (0.54) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Altman-Z -0.26
ROIC/WACC0.4
WACC9.66%
AIRI Yearly LT Debt VS Equity VS FCFAIRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

AIRI has a Current Ratio of 1.44. This is a normal value and indicates that AIRI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AIRI (1.44) is worse than 67.19% of its industry peers.
A Quick Ratio of 0.30 indicates that AIRI may have some problems paying its short term obligations.
AIRI's Quick ratio of 0.30 is on the low side compared to the rest of the industry. AIRI is outperformed by 96.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.3
AIRI Yearly Current Assets VS Current LiabilitesAIRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

4

3. Growth

3.1 Past

AIRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.78%, which is quite impressive.
AIRI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.30%.
Measured over the past years, AIRI shows a small growth in Revenue. The Revenue has been growing by 2.96% on average per year.
EPS 1Y (TTM)79.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)3.3%
Revenue growth 3Y0.93%
Revenue growth 5Y2.96%
Sales Q2Q%2.13%

3.2 Future

The Earnings Per Share is expected to grow by 39.04% on average over the next years. This is a very strong growth
Based on estimates for the next years, AIRI will show a small growth in Revenue. The Revenue will grow by 4.42% on average per year.
EPS Next Y80%
EPS Next 2Y39.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.42%
Revenue Next 2Y4.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AIRI Yearly Revenue VS EstimatesAIRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
AIRI Yearly EPS VS EstimatesAIRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4 -6

2

4. Valuation

4.1 Price/Earnings Ratio

AIRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIRI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIRI Price Earnings VS Forward Price EarningsAIRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AIRI is valued cheaper than 85.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.24
AIRI Per share dataAIRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

AIRI's earnings are expected to grow with 39.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.04%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AIRI!.
Industry RankSector Rank
Dividend Yield N/A

AIR INDUSTRIES GROUP

NYSEARCA:AIRI (2/21/2025, 8:04:00 PM)

After market: 3.8522 -0.05 (-1.23%)

3.9

-0.05 (-1.27%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)03-31 2025-03-31/amc
Inst Owners7.47%
Inst Owner Change-69.55%
Ins Owners5.48%
Ins Owner Change0.95%
Market Cap13.10M
Analysts82.86
Price Target7.91 (102.82%)
Short Float %0.57%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-173.11%
Min EPS beat(2)-488.23%
Max EPS beat(2)142.02%
EPS beat(4)2
Avg EPS beat(4)-75.12%
Min EPS beat(4)-488.23%
Max EPS beat(4)142.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.43%
Min Revenue beat(2)-4.03%
Max Revenue beat(2)10.88%
Revenue beat(4)3
Avg Revenue beat(4)4.85%
Min Revenue beat(4)-4.03%
Max Revenue beat(4)10.88%
Revenue beat(8)3
Avg Revenue beat(8)-0.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.86%
Revenue beat(16)6
Avg Revenue beat(16)-2.07%
PT rev (1m)0%
PT rev (3m)-22.5%
EPS NQ rev (1m)-75%
EPS NQ rev (3m)128.57%
EPS NY rev (1m)-320%
EPS NY rev (3m)-320%
Revenue NQ rev (1m)-4.93%
Revenue NQ rev (3m)-3.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.89
EV/EBITDA 12.24
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS15.97
BVpS4.37
TBVpS4.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.25%
ROE -4.3%
ROCE 4.87%
ROIC 3.85%
ROICexc 3.88%
ROICexgc 3.88%
OM 2.14%
PM (TTM) N/A
GM 16.1%
FCFM N/A
ROA(3y)-1.05%
ROA(5y)-1.32%
ROE(3y)-3.69%
ROE(5y)-6.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.53%
GM growth 5Y3.33%
F-Score3
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Debt/EBITDA 2.56
Cap/Depr 89.94%
Cap/Sales 3.27%
Interest Coverage 0.63
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.3
Altman-Z -0.26
F-Score3
WACC9.66%
ROIC/WACC0.4
Cap/Depr(3y)78.55%
Cap/Depr(5y)81.77%
Cap/Sales(3y)3.62%
Cap/Sales(5y)3.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y80%
EPS Next 2Y39.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.3%
Revenue growth 3Y0.93%
Revenue growth 5Y2.96%
Sales Q2Q%2.13%
Revenue Next Year7.42%
Revenue Next 2Y4.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y174.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year382.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-294.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-216.42%
OCF growth 3YN/A
OCF growth 5YN/A